申请人:Beecham Group Limited
公开号:US04327099A1
公开(公告)日:1982-04-27
Compounds of the formula (I): ##STR1## wherein R.sub.1 and R.sub.2 are independently selected from a hydrogen atom and a C.sub.1-3 alkyl group; R.sub.3 is a hydrogen atom, a C.sub.1-3 alkyl or C.sub.2-4 acyl group; R.sub.4 is a hydrogen atom or C.sub.1-5 alkyl group; R.sub.5 is a C.sub.1-5 alkyl group, a straight chain C.sub.1-3 alkyl group terminally substituted by a chlorine atom; or R.sub.4 and R.sub.5 are joined so that together with the nitrogen atom to which they are attached they form a 5-, 6- or 7-membered ring optionally containing an oxygen or sulphur atom; R.sub.6 is a hydrogen atom, or a C.sub.1-5 alkyl, phenyl, CF.sub.3 or XH group wherein X is an oxygen or sulphur atom, the dotted line represents a bond, and R.sub.7 is not present; or R.sub.6 is an oxygen atom joined to the ring carbon atom by a double bond, the dotted line is not present, and R.sub.7 is hydrogen; the NR.sub.4 R.sub.5 and OR.sub.3 moieties are trans; and pharmaceutically acceptable salts thereof having antihypertensive activity, processes for their preparation and their use in compositions.
式(I)的化合物:其中R.sub.1和R.sub.2分别从氢原子和C.sub.1-3烷基组中选择;R.sub.3是氢原子,C.sub.1-3烷基或C.sub.2-4酰基;R.sub.4是氢原子或C.sub.1-5烷基;R.sub.5是C.sub.1-5烷基,一条直链C.sub.1-3烷基末端被氯原子取代;或R.sub.4和R.sub.5连接在一起,与它们附着的氮原子一起形成一个含有氧原子或硫原子的5、6或7元环;R.sub.6是氢原子,或C.sub.1-5烷基、苯基、CF.sub.3或XH组,其中X是氧原子或硫原子,虚线表示键,R.sub.7不存在;或R.sub.6是通过双键连接到环碳原子的氧原子,虚线不存在,R.sub.7是氢;NR.sub.4R.sub.5和OR.sub.3基团为反式;及其具有降压活性的药用盐,其制备方法及其在配方中的使用。